Lurasidone Hydrochloride and Norvir (Ritonavir Powder Packets)
Determining the interaction of Lurasidone Hydrochloride and Norvir (Ritonavir Powder Packets) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using lurasidone together with ritonavir is not recommended. Combining these medications may significantly increase the blood levels of lurasidone. This may increase the risk of side effects such as Parkinson-like symptoms, abnormal muscle movements, seizures, high blood sugar, diabetes, high cholesterol, sex hormone irregularities, and heat-related disorders such as heat intolerance or heat stroke. You may also be more likely to experience side effects associated with low blood pressure such as dizziness, lightheadedness, headache, flushing, fainting, and heart palpitations. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:CONTRAINDICATED: Coadministration with potent inhibitors of CYP450 3A4 may significantly increase the plasma concentrations of lurasidone and its active metabolite, both of which are primarily metabolized by the isoenzyme. In a pharmacokinetic study, administration of a single 10 mg dose of lurasidone with the potent CYP450 3A4 inhibitor ketoconazole (400 mg/day for 5 days) resulted in a 6.9-fold increase in lurasidone peak plasma concentration (Cmax) and a 9-fold increase in systemic exposure (AUC) compared to administration alone. The AUC of lurasidone's active metabolite increased by 6-fold.
MANAGEMENT: Concomitant use of lurasidone with potent CYP450 3A4 inhibitors is considered contraindicated.
- "Product Information. Latuda (lurasidone)." Sunovion Pharmaceuticals Inc, Marlborough, MA.
- Cerner Multum, Inc. "Australian Product Information." O 0
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: lurasidone
Brand name: Latuda
Synonyms: Lurasidone
Generic Name: ritonavir
Brand name: Norvir, Norvir Soft Gelatin
Synonyms: Norvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lurasidone Hydrochloride-Norvir (Ritonavir Tablets)
- Lurasidone Hydrochloride-Norvir Tablets
- Lurasidone Hydrochloride-Norwich Aspirin
- Lurasidone Hydrochloride-Nostril
- Lurasidone Hydrochloride-Nostrilla
- Lurasidone Hydrochloride-Notuss-Forte
- Norvir (Ritonavir Powder Packets)-Lurasidone Tablets
- Norvir (Ritonavir Powder Packets)-Lusedra
- Norvir (Ritonavir Powder Packets)-Lusonal
- Norvir (Ritonavir Powder Packets)-Lutathera
- Norvir (Ritonavir Powder Packets)-Lutera
- Norvir (Ritonavir Powder Packets)-Lutetium Lu 177 dotatate